HAIKOU CITY, China, Nov. 4 /Xinhua-PRNewswire-FirstCall/ -- China
Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), a
specialty pharmaceutical company which develops, manufactures, and markets
its products in China, today announced that senior management will present
a corporate overview at two upcoming U.S. conferences.
-- Rodman and Renshaw's Annual Global Investment Conference (Asia and
Growth Track) will be held November 10-12, 2008 at the New York Palace
Hotel in New York City, New York. The Company's presentation will take
place on Monday, November 10th at 5:20pm ET in Henry Salon (5th Floor).
-- Roth Capital's "China Comes to Vegas" conference will be held November
19-21, 2008 at the Wynn Hotel in Las Vegas, Nevada. The Company's
presentation will take place on Friday, November 21st at 9:30am ET in
Palmer 2 - Track 2.
President and CEO, Ms. Zhilin Li, and CFO, Mr. Xinhua Wu, will attend and are available for one-on-one meetings during both conferences to highlight China Pharma Holding's current product portfolio, development pipeline, research and development platform, recent financial highlights and growth strategy.
Ms. Li commented, "I am delighted to visit the US and meet with investors and analysts. I consider these conferences a great opportunity to listen to their ideas, develop mutual understanding, and raise China Pharma's profile in the US. Our goal of this trip is to better understand the US capital markets in order to improve our communications and performance for shareholders."
A live audio webcast of China Pharma Holding's presentation at Roth Capital's conference will be available at http://www.wsw.com/webcast/roth18/cphi.ob and accessible for 90 days following the presentation. Please log on 15 minutes prior to the presentation to download any necessary materials.
For more information on Roth Capital's "China Comes to Vegas" Conference, dedicated to Chinese-based, U.S. listed companies, please visit http://www.roth.com .
For more information on Rodman & Renshaw's Annual Global Investment Conference, featuring Steel, Metals & Mining, Energy, Healthcare, Asia & Growth and SPACs Tracks, please visit http://www.rodmanandrenshaw.com/conferences .
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a biopharmaceutical company with rapidly growing profit that develops, manufactures, and markets treatments for a wide range of high incidence and high mortality conditions in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost- effective, high margin business model is driven by market demand and supported by 8 scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding distribution network across more than 29 provinces, municipalities and autonomous regions. The Company is registered in Delaware, USA. Hainan Helpson Bio-pharmaceutical Co., Ltd (Helpson), located in Haikou City, Hainan Province, China, is a wholly owned subsidiary of China Pharma Holdings, Inc. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com .
Safe Harbor Statement
Certain statements in this press release and oral statements made by
China Pharma on its conference call in relation to this release, constitute
forward-looking statements for purposes of the safe harbor provisions under
The Private Securities Litigation Reform Act of 1995. Any statements set
forth above that are not historical facts are forward-looking statements
that involve risks and uncertainties that could cause actual results to
differ materially from those in the forward-looking statements, which may
include, but are not limited to, such factors as unanticipated changes in
product demand, increased competition, failure to obtain or maintain
intellectual property protection, downturns in the Chinese economy,
uncompetitive levels of research and development, failure to obtain
regulatory approvals, and other information detailed from time to time in
the Company's filings and future filings with the United States Securities
and Exchange Commission. The forward-looking statements made herein speak
only as of the date of this press release and the Company undertakes no
duty to update any forward-looking statement to conform the statement to
actual results or changes in the company's expectations.
For further information, please contact:
China Pharma Holdings, Inc.
The Ruth Group
|SOURCE China Pharma Holdings, Inc.|
Copyright©2008 PR Newswire.
All rights reserved